The loss of PTEN during the early stages of prostate cancer elicits compensatory changes that oppose tumorigenesis, and additional mutations are required to stimulate progression to advanced stages of prostate cancer [5,6]. The gene discussed is PTEN; the disease is Familial prostate cancer.